Top Markets
Coin of the day
Verici Dx plc Verici Dx plc

Verici Dx plc

VRCI
Rank in Stocks #40970
Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney... Verici Dx plc is an immuno-diagnostics company primarily focused on the kidney transplantation sector. The firm specializes in creating both predictive and diagnostic assays for patients who have undergone kidney transplants. Its development pipeline features Clarava, a pre-transplant tool designed to forecast the likelihood of early acute rejection; Tuteva, a post-transplant assessment focusing on acute cellular rejection; and Protega, an innovative liquid biopsy aiming to predict the risk of fibrosis and eventual graft failure. Established in 2020, Verici Dx plc maintains its headquarters in Penarth, United Kingdom.
Share Price
$0.00340175
Market Cap
$56.86K
Change (1 day)
0.00%
Change (1 year)
-52.28%
Country
GB
Trade Verici Dx plc (VRCI)

Category

Dividend yield history for Verici Dx plc (VRCI)
Verici Dx plc (stock symbol: VRCI) dividend yield (TTM) as of 2026: 0
Average dividend yield, last 5 years : 0.00%
Dividend yield history for Verici Dx plc (VRCI) from 2026 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
Not enough data for the provided dates.
Dividend yields (TTM) for similar companies or competitors